Skip to content

News Press Releases

Raydiant Oximetry Names Michael Nagel to Lead the Company into its Device Commercialization Stage as CEO

SAN RAMON, CA, UNITED STATES, September 16, 2025 — Raydiant Oximetry, Inc. a clinical-stage medical device company developing fetal monitoring innovations using advanced biophotonics and machine learning to improve outcomes during childbirth, today announced the appointment of Michael Nagel as Chief Executive Officer.

Read the full release on einpresswire.com